MiR-221 and miR-222 simultaneously target ARID1A and enhance proliferation and invasion of cervical cancer cells

European Review for Medical and Pharmacological Sciences

Volumn 20, Issue 8, 2016, Pages 1509-1515

  Yang, Y ^a   Zhao, X ^a   Li, H X ^a  

^a Peking University Civil Aviation School of Clinical Medicine   (China)

Author keywords

ARID1A; Cervical cancer; miR 221; miR 222

Indexed keywords

AT RICH INTERACTIVE DOMAIN CONTAINING PROTEIN 1A; MICRORNA 221; MICRORNA 222; TRANSCRIPTION FACTOR SNF; UNCLASSIFIED DRUG; ARID1A PROTEIN, HUMAN; MICRORNA; MIRN221 MICRORNA, HUMAN; MIRN222 MICRORNA, HUMAN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

3' UNTRANSLATED REGION; ARID1A GENE; ARTICLE; BINDING SITE; CELL CYCLE S PHASE; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CERVICAL CANCER CELL LINE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; SIHA CELL LINE; TUMOR SUPPRESSOR GENE; UPREGULATION; UTERINE CANCER CELL LINE; WESTERN BLOTTING; UTERINE CERVIX TUMOR;

FEMALE; HUMANS; MICRORNAS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 85017191430     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. SIEGEL R, MA J, ZOU Z, JEMAL A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
2. MUNAGALA R, KAUSAR H, MUNJAL C, GUPTA RC. Witha-ferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Carcino-genesis 2011;32:1697-1705.
3. YANG L, BAI HS, DENG Y, FAN L. High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion. Eur Rev Med Pharmacol Sci 2015;19:3187-3193.
4. MADEDDU G, MAMELI G, CAPOBIANCO G, BABUDIERI S, MAIDA I, BAGELLA P, ROCCA G, CHERCHI PL, SECHI LA, ZANETTI S, NUNNARI G, DESSOLE S, MURA MS. HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART. Eur Rev Med Pharmacol Sci 2014;18:1277-1285.
5. LI JG, LI L, ZHANG SW. Different Expression of p16INK4a and p14ARF in cervical and lung cancers. Eur Rev Med Pharmacol Sci 2013;17:3007-3011.
6. WOODMAN CB, COLLINS SI, YOUNG LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007;7:11-22.
7. GHITTONI R, ACCARDI R, HASAN U, GHEIT T, SYLLA B, TOMMASINO M. The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes 2010;40:1-13.
8. BANNO K, IIDA M, YANOKURA M, KISU I, IWATA T, TOMINA-GA E, TANAKA K, AOKI D. MicroRNA in cervical cancer: OncomiRs and tumor suppressor miRs in diagnosis and treatment. Sci WorldJ 2014;2014:178075.
9. GOCZE K, GOMBOS K, JUHASZ K, KOVACS K, KAJTAR B, BENCZIK M, GOCZE P, PATCZAI B, ARANY I, EMBER I. Unique microRNA expression profiles in cervical cancer. Anticancer Res 2013;33:2561-2567.
10. WALD AI, HOSKINS EE, WELLS SI, FERRIS RL, KHAN SA. Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human pap-illomavirus. Head Neck 2011;33:504-512.
11. SUN Y, ZHANG B, CHENG J, WU Y, XING F, WANG Y, WANG Q, QIU J. MicroRNA-222 promotes the proliferation and migration of cervical cancer cells. Clin Invest Med 2014;37:E131.
12. DU J, WANG L, LI C, YANG H, LI Y, HU H, LI H, ZHANG Z. MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to geftinib through the PI3K/Akt signaling pathway. Tumour Biol 2015.
13. KATAGIRI A, NAKAYAMA K, RAHMAN MT, RAHMAN M, KATAGIRI H, ISHIKAWA M, ISHIBASHI T, IIDA K, OTSUKI Y, NAKAYAMA S, MIYAZAKI K. Frequent loss of tumor suppressor ARID1A protein expression in adenocarcino-mas/adenosquamous carcinomas of the uterine cervix. Int J Gynecol Cancer 2012;22:208-212.
14. WANG N, ZHOU Y, ZHENG L, LI H. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A. Gynecol Oncol 2014;134:129-137.
15. LIU S, SONG L, ZHANG L, ZENG S, GAO F. miR-21 modulates resistance of HR-HPV positive cervical cancer cells to radiation through targeting LATS1. Biochem Biophys Res Commun 2015;459:679-685.
16. XIONG W, ZHANG L, XIONG Y, LIU H, LIU Y. Hypoxia Promotes Invasion of Endometrial Stromal Cells via Hypoxia-Inducible Factor 1alpha Upregulation-Me-diated beta-Catenin Activation in Endometriosis. Re-prod Sci 2015.
17. PARK JH, LEE C, SUH JH, CHAE JY, KIM HW, MOON KC. Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma. Hum Pathol 2015;46:454-460.
18. JIANG ZH, DONG XW, SHEN YC, QIAN HL, YAN M, YU ZH, HE HB, LU CD, QIU F. DNA damage regulates ARID1A stability via SCF ubiquitin ligase in gastric cancer cells. Eur Rev Med Pharmacol Sci 2015;19:3194-3200.
19. LAO G, LIU P, WU Q, ZHANG W, LIU Y, YANG L, MA C. Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1. Tumour Biol 2014;35:11933-11938.
20. WEI Q, LI YX, LIU M, LI X, TANG H. MiR-17-5p targets TP53INP1 and regulates cell proliferation and apopto-sis of cervical cancer cells. IUBMB Life 2012;64:697-704.
21. WEN SY, LIN Y, YU YQ, CAO SJ, ZHANG R, YANG XM, LI J, ZHANG YL, WANG YH, MA MZ, SUN WW, LOU XL, WANG JH, TENG YC, ZHANG ZG. miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer. Oncogene 2015;34:717-725.
22. YIN ZL, WANG YL, GE SF, GUO TT, WANG L, ZHENG XM, LIU J. Reduced expression of miR-503 is associated with poor prognosis in cervical cancer. Eur Rev Med Pharmacol Sci 2015;19:4081-4085.
23. HUANG J, ZHAO YL, LI Y, FLETCHER JA, XIAO S. Genomic and functional evidence for an ARID1A tumor suppressor role. Genes Chromosomes Cancer 2007;46:745-750.
24. NAG NG, JR., WANG X, PATSIALOU A, VAN SCOY M, MO-RAN E. Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. EMBO J 2007;26:752-763.
25. GUAN B, WANG TL, SHIH IE M. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res 2011;71:6718-6727.
26. CHO H, KIM JS, CHUNG H, PERRY C, LEE H, KIM JH. Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer. Hum Pathol 2013;44:1365-1374.